DGAP-News: PAION AG / Key word(s): Change of Personnel ABDELGHANI OMARI APPOINTED AS NEW CHIEF FINANCIAL OFFICER AT PAION AG 27.08.2014 / 10:10 --------------------------------------------------------------------- ABDELGHANI OMARI APPOINTED AS NEW CHIEF FINANCIAL OFFICER AT PAION AG Aachen (Germany), 27 August 2014 - PAION AG, a Specialty Pharma Company (ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8) announces that Abdelghani Omari (37) has been appointed by the Supervisory Board as a new member of the Management Board of PAION AG and is Chief Financial Officer with effect from 1 September 2014. Abdelghani Omari has been with PAION as Vice President Finance since October 2008 and after the departure of Bernhard Hofer as CFO in early 2012 he has taken over his duties but reporting to the management board. Mr Omari has intensively worked on the restructuring process and the repositioning of PAION AG in the last years and was responsible and involved in various capital market transactions and licensing agreements as Vice President Finance. Prior to joining PAION AG, Abdelghani Omari held various positions at KPMG, Cologne in auditing and advisory. He studied at the University of Aachen and has a Diploma in Business Administration. "I am delighted to win an experienced financial expert from among our ranks to the position of CFO. Mr. Omari has excellent knowledge of PAION's business model and will accompany the company in an even stronger position on the path through the Phase III program up to approval and commercialization. I wish him continued success in his new function," says Dr. Jörg Spiekerkötter, Chairman of the Supervisory Board of PAION AG. "Since 2012, we have jointly conducted a total of seven product-related transactions and three financial market transactions. Mr Omari's entrepreneurial determination combined with the sensitivity for the respective financial risks has contributed significantly to the current position of PAION," commented Dr. Wolfgang Söhngen, CEO of PAION. ### About PAION PAION AG is a publicly-listed Specialty Pharma Company headquartered in Aachen, Germany with a second site in Cambridge, UK. The company has a track record in developing hospital-based treatments for which there is substantial unmet medical need. PAION's strategy is to extend its business model from a pure development company to a specialty pharmaceutical company with a focus on anaesthesia products. Remimazolam is intended to be the basis for its future marketing activities. PAION Contact Ralf Penner Director Investor Relations / Public Relations PAION AG Martinstrasse 10-12 52062 Aachen - Germany Phone: +49 241 4453-152 E-mail: r.penner@paion.com www.paion.com Disclaimer: This release contains certain forward-looking statements concerning the future business of PAION AG. These forward-looking statements contained herein are based on the current expectations, estimates and projections of PAION AG's management as of the date of this release. They are subject to a number of assumptions and involve known and unknown risks, uncertainties and other factors. Should actual conditions differ from the Company's assumptions, actual results and actions may differ materially from any future results and developments expressed or implied by such forward-looking statements. Considering the risks, uncertainties and other factors involved, recipients should not rely unreasonably upon these forward-looking statements. PAION AG has no obligation to periodically update any such forward-looking statements to reflect future events or developments. --------------------------------------------------------------------- 27.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: PAION AG Martinstr. 10-12 52062 Aachen Germany Phone: +49 (0)241-4453-0 Fax: +49 (0)241-4453-100 E-mail: info@paion.com Internet: www.paion.com ISIN: DE000A0B65S3 WKN: A0B65S Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 283966 27.08.2014
DGAP-News: ABDELGHANI OMARI APPOINTED AS NEW CHIEF FINANCIAL OFFICER AT PAION AG
| Source: EQS Group AG